Article info
PDFInterstitial lung disease
Original research
Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality
- Correspondence to Dr Steven D Nathan, Heart and Lung Transplant Center, Inova Fairfax Hospital, Falls Church, VA 22042, USA; steven.nathan@inova.org
Citation
Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality
Publication history
- Received August 7, 2023
- Accepted November 2, 2023
- First published November 18, 2023.
Online issue publication
March 15, 2024
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.